Key Events This Week
18 May: Intraday high surge with 7.96% gain
19 May: Technical momentum shift amid mixed signals
20 May: Mojo Score upgraded to Sell from Strong Sell
22 May: Week closes at Rs.772.65, +14.15% for the week
Jun 12, 03:30 PM
BSE+NSE Vol: 30.54 k

Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 8 June 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting a reassessment of its risk and return profile by analysts at MarketsMOJO.
Read full news article
The Sensex declined by 0.85% on 8 Jun 2026, while Astec Lifesciences Ltd surged 7.44%, outperforming its sector by 4.17 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has exhibited a notable shift in price momentum, moving from a sideways trend to a mildly bullish stance. Despite a strong day change of 6.65%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical developments, price action, and relative performance against the broader market to provide investors with a comprehensive view.
Read full news article
While the Sensex slipped 0.27% on 2 Jun 2026, Astec Lifesciences Ltd surged 8.17%, touching an intraday high of Rs 794.9. This 7.42-percentage-point outperformance over its Pesticides & Agrochemicals sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial trends, challenging valuation metrics, and subdued quality scores, signalling heightened risk for investors despite some recent operational improvements.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s price action and technical indicators reveal a nuanced picture that investors should carefully analyse.
Read full news article
Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
The Sensex edged up a modest 0.11% on 29 May 2026, while Astec Lifesciences Ltd surged 11.39%, marking a standout session in the Pesticides & Agrochemicals sector with an outperformance of nearly 11 percentage points. This sharp intraday gain rewrites the short-term narrative for the stock, raising the question of whether this is a breakout or a recovery rally within a broader trend.
Read full news article